Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/23/21
End: 01/21/22
Due: 01/21/23
Phase: N/A
Priority: Normal
Start: 11/19/18
End: 05/31/19
Due: 05/31/20
Phase: N/A
Priority: Normal
Start: 09/30/22
End: 04/30/25
Due: 04/30/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Retrospective Study of Subjects With Thymidine Kinase 2 Deficiency | NCT05017818 | Zogenix MDS, Inc. | user2@example.com | None | 2021-07-23 | 2022-01-21 | 2023-01-21 | - | - | 2025-07-14 |
| A RETROspective Study of Patients With TK2d | NCT03701568 | Zogenix MDS, Inc. | user2@example.com | None | 2018-11-19 | 2019-05-31 | 2020-05-31 | - | - | 2025-07-14 |
| A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve) | NCT04581733 | Zogenix MDS, Inc. | user2@example.com | None | 2022-09-30 | 2025-04-30 | 2026-04-30 | - | - | 2025-07-14 |